首页 > 最新文献

02.01 - Acute critical care最新文献

英文 中文
Spontaneous pneumothorax and factors associated with its development in a cohort of COVID-19 patients in Latin America 拉丁美洲一组COVID-19患者的自发性气胸及其发展相关因素
Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.3
L. Dulcey, R. Caltagirone, J. Theran, D. Villamizar, M. Aguas, H. Moreno, J. Pineda, R. Parales
{"title":"Spontaneous pneumothorax and factors associated with its development in a cohort of COVID-19 patients in Latin America","authors":"L. Dulcey, R. Caltagirone, J. Theran, D. Villamizar, M. Aguas, H. Moreno, J. Pineda, R. Parales","doi":"10.1183/13993003.congress-2022.3","DOIUrl":"https://doi.org/10.1183/13993003.congress-2022.3","url":null,"abstract":"","PeriodicalId":289883,"journal":{"name":"02.01 - Acute critical care","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132362464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can initial Chest CT scan findings predict high flow nasal cannula (HFNC) failure in critically ill COVID19 patients 胸部CT初步扫描结果能否预测covid - 19危重患者高流量鼻插管失败
Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.4096
H. Zorgati, D. Ben Braiek, I. Mighri, S. Ben Mansour, O. Saadaoui, R. Hidri, A. Douzi, C. Kaabi, A. Azaza, O. Ghabi, R. Ben Jazia, A. Kacem, I. Kharrat, J. Ayachi
{"title":"Can initial Chest CT scan findings predict high flow nasal cannula (HFNC) failure in critically ill COVID19 patients","authors":"H. Zorgati, D. Ben Braiek, I. Mighri, S. Ben Mansour, O. Saadaoui, R. Hidri, A. Douzi, C. Kaabi, A. Azaza, O. Ghabi, R. Ben Jazia, A. Kacem, I. Kharrat, J. Ayachi","doi":"10.1183/13993003.congress-2022.4096","DOIUrl":"https://doi.org/10.1183/13993003.congress-2022.4096","url":null,"abstract":"","PeriodicalId":289883,"journal":{"name":"02.01 - Acute critical care","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121463982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
One year overview of follow-up in a post-covid consultation of critical patients with covid-19 covid-19危重患者covid-19后会诊随访一年概况
Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.1674
J. González Gutiérrez, M. Zuil, I. D. Benítez, M. Aguilà, S. Santisteve, F. Seck, A. Moncusí-Moix, C. Gort-Paniello, A. Torres, F. Barbé
{"title":"One year overview of follow-up in a post-covid consultation of critical patients with covid-19","authors":"J. González Gutiérrez, M. Zuil, I. D. Benítez, M. Aguilà, S. Santisteve, F. Seck, A. Moncusí-Moix, C. Gort-Paniello, A. Torres, F. Barbé","doi":"10.1183/13993003.congress-2022.1674","DOIUrl":"https://doi.org/10.1183/13993003.congress-2022.1674","url":null,"abstract":"","PeriodicalId":289883,"journal":{"name":"02.01 - Acute critical care","volume":"68 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123494667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-flow nasal cannula versus noninvasive ventilation in the prevention of escalation to invasive mechanical ventilation in patients with acute hypoxemic respiratory failure 高流量鼻插管与无创通气预防急性低氧性呼吸衰竭患者升级为有创机械通气的比较
Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.4700
G. Agmy, M. Adam, M. Elkhawaga, E. Hsanen
{"title":"High-flow nasal cannula versus noninvasive ventilation in the prevention of escalation to invasive mechanical ventilation in patients with acute hypoxemic respiratory failure","authors":"G. Agmy, M. Adam, M. Elkhawaga, E. Hsanen","doi":"10.1183/13993003.congress-2022.4700","DOIUrl":"https://doi.org/10.1183/13993003.congress-2022.4700","url":null,"abstract":"","PeriodicalId":289883,"journal":{"name":"02.01 - Acute critical care","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114968047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ventilator associated pneumonia surveillance in critically ill patients with COVID-19 in a tertiary care hospital 某三级医院COVID-19危重患者呼吸机相关性肺炎监测
Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.2690
D. Karadeniz Güven, G. Telli Dizman, G. Metan, G. Durhan, A. Topeli, A. Demir
{"title":"Ventilator associated pneumonia surveillance in critically ill patients with COVID-19 in a tertiary care hospital","authors":"D. Karadeniz Güven, G. Telli Dizman, G. Metan, G. Durhan, A. Topeli, A. Demir","doi":"10.1183/13993003.congress-2022.2690","DOIUrl":"https://doi.org/10.1183/13993003.congress-2022.2690","url":null,"abstract":"","PeriodicalId":289883,"journal":{"name":"02.01 - Acute critical care","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116839943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phase 3 RCT of C5a-Specific Vilobelimab in Severe COVID-19 Pneumonia c5a特异性Vilobelimab治疗重症COVID-19肺炎的3期RCT
Pub Date : 2022-09-04 DOI: 10.1183/13993003.congress-2022.4725
A. Vlaar, G. Hermans, M. Witzenrath, P. van Paassen, L. Heunks, B. Mourvillier, S. de Bruin, E. L. Lim, M. Piagnerelli, A. Roquilly, J. Lascarrou, M. Bauer, C. Schwebel, M. Brouwer, P. Tuinman, T. Welte, G. Marx, U. Jaschinski, A. Cornet, A. Grebenyuk, P. Jorens, S. Rückinger, K. Pilz, C. Thielert, D. Neukirchen, L. Ruckerbauer, B. Burnett, R. Guo, D. van de Beek, N. Riedemann
{"title":"Phase 3 RCT of C5a-Specific Vilobelimab in Severe COVID-19 Pneumonia","authors":"A. Vlaar, G. Hermans, M. Witzenrath, P. van Paassen, L. Heunks, B. Mourvillier, S. de Bruin, E. L. Lim, M. Piagnerelli, A. Roquilly, J. Lascarrou, M. Bauer, C. Schwebel, M. Brouwer, P. Tuinman, T. Welte, G. Marx, U. Jaschinski, A. Cornet, A. Grebenyuk, P. Jorens, S. Rückinger, K. Pilz, C. Thielert, D. Neukirchen, L. Ruckerbauer, B. Burnett, R. Guo, D. van de Beek, N. Riedemann","doi":"10.1183/13993003.congress-2022.4725","DOIUrl":"https://doi.org/10.1183/13993003.congress-2022.4725","url":null,"abstract":"","PeriodicalId":289883,"journal":{"name":"02.01 - Acute critical care","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116891893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of patients with initial acute respiratory failure on veno-venous extracorporeal membrane oxygenation (ECMO) requiring additional circulatory support by VVA ECMO 静脉-静脉体外膜氧合(ECMO)初始急性呼吸衰竭患者需要额外的VVA ECMO循环支持的结果
Pub Date : 2022-02-17 DOI: 10.21203/rs.3.rs-1358518/v1
R. Erlebach, Lennart C. Wild, B. Seeliger, A. Rath, Rea Andermatt, D. Hofmaenner, J. Schewe, C. Ganter, C. Putensen, R. Natanov, C. Kühn, J. Bauersachs, T. Welte, M. Hoeper, P. Wendel-Garcia, S. David, C. Bode, K. Stahl, BonHanZA (Bonn-Hannover-Zurich-ARDS) study group BonHanZA ( group
Background: Veno-venous (VV) extracorporeal membrane oxygenation (ECMO) is increasingly used to support patients with severe acute respiratory distress syndrome (ARDS). In case of additional cardio-circulatory failure, some experienced centers upgrade the VV-ECMO with an additional arterial backflow cannula (termed VVA-ECMO). Here we analyzed short- and long-term outcome together with potential predictors of mortality. Methods: Retrospective analysis of outcome in VV ECMO patients with ARDS that received VVA upgrade due to acute cardio-circulatory deterioration from 2008-2021 at three ECMO referral centers.Results: We identified 73 VVA ECMO patients that either required an upgrade from VV to VVA (n=53) or were directly triple cannulated (n=20), most commonly for concomitant right-sided heart failure. Median (Interquartile Range) age was 49 (28-57) years and SOFA score was 14 (12-17) at VVA ECMO upgrade. ECMO support was required over 12 (6-22) days and ICU length of stay was 32 (16-46) days. Overall ICU mortality was 48% and hospital mortality 51%. Two additional patients died after hospital discharge while the remaining patients survived up to two years (with six patients being lost to follow-up). A SOFA score > 14 at the day of VVA upgrade and higher lactate level were independent predictors of mortality in the multivariate regression analysis.Conclusions: In this analysis, the use of VVA ECMO in patients with initial ARDS and concomitant cardiocirculatory failure was associated with a hospital survival of about 50%, and most of these patients survived up to 2 years. A SOFA score >14 and elevated lactate levels at the day of VVA upgrade predict unfavorable outcome.
背景:静脉-静脉(VV)体外膜氧合(ECMO)越来越多地用于支持严重急性呼吸窘迫综合征(ARDS)患者。如果出现额外的心肺功能衰竭,一些经验丰富的中心会将VV-ECMO升级为额外的动脉回流插管(称为VVA-ECMO)。在这里,我们分析了短期和长期结果以及潜在的死亡率预测因素。方法:回顾性分析2008-2021年三个ECMO转诊中心因急性心肺功能恶化而接受VVA升级的VV ECMO ARDS患者的结局。结果:我们确定了73例VVA ECMO患者,这些患者要么需要从VV升级到VVA (n=53),要么直接进行三管插管(n=20),最常见的是合并右侧心力衰竭。VVA ECMO升级时的中位年龄(四分位差)为49岁(28-57岁),SOFA评分为14分(12-17分)。ECMO支持超过12(6-22)天,ICU住院时间为32(16-46)天。ICU总死亡率为48%,医院死亡率为51%。另外2例患者出院后死亡,其余患者存活长达2年(6例患者失去随访)。在多因素回归分析中,VVA升级当天SOFA评分> 14和较高的乳酸水平是死亡率的独立预测因子。结论:在本分析中,VVA ECMO用于首发ARDS并伴有心循环衰竭的患者,其住院生存率约为50%,其中大多数患者存活时间长达2年。SOFA评分>14和VVA升级当天乳酸水平升高预示不良结果。
{"title":"Outcomes of patients with initial acute respiratory failure on veno-venous extracorporeal membrane oxygenation (ECMO) requiring additional circulatory support by VVA ECMO","authors":"R. Erlebach, Lennart C. Wild, B. Seeliger, A. Rath, Rea Andermatt, D. Hofmaenner, J. Schewe, C. Ganter, C. Putensen, R. Natanov, C. Kühn, J. Bauersachs, T. Welte, M. Hoeper, P. Wendel-Garcia, S. David, C. Bode, K. Stahl, BonHanZA (Bonn-Hannover-Zurich-ARDS) study group BonHanZA ( group","doi":"10.21203/rs.3.rs-1358518/v1","DOIUrl":"https://doi.org/10.21203/rs.3.rs-1358518/v1","url":null,"abstract":"\u0000 Background: Veno-venous (VV) extracorporeal membrane oxygenation (ECMO) is increasingly used to support patients with severe acute respiratory distress syndrome (ARDS). In case of additional cardio-circulatory failure, some experienced centers upgrade the VV-ECMO with an additional arterial backflow cannula (termed VVA-ECMO). Here we analyzed short- and long-term outcome together with potential predictors of mortality. Methods: Retrospective analysis of outcome in VV ECMO patients with ARDS that received VVA upgrade due to acute cardio-circulatory deterioration from 2008-2021 at three ECMO referral centers.Results: We identified 73 VVA ECMO patients that either required an upgrade from VV to VVA (n=53) or were directly triple cannulated (n=20), most commonly for concomitant right-sided heart failure. Median (Interquartile Range) age was 49 (28-57) years and SOFA score was 14 (12-17) at VVA ECMO upgrade. ECMO support was required over 12 (6-22) days and ICU length of stay was 32 (16-46) days. Overall ICU mortality was 48% and hospital mortality 51%. Two additional patients died after hospital discharge while the remaining patients survived up to two years (with six patients being lost to follow-up). A SOFA score > 14 at the day of VVA upgrade and higher lactate level were independent predictors of mortality in the multivariate regression analysis.Conclusions: In this analysis, the use of VVA ECMO in patients with initial ARDS and concomitant cardiocirculatory failure was associated with a hospital survival of about 50%, and most of these patients survived up to 2 years. A SOFA score >14 and elevated lactate levels at the day of VVA upgrade predict unfavorable outcome.","PeriodicalId":289883,"journal":{"name":"02.01 - Acute critical care","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127654744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
02.01 - Acute critical care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1